Abstract
Background
Porokeratosis (PK) is a rare skin disease of unknown etiology. It consists of a keratinization disorder, which may appear in several clinical forms and can undergo malignant transformation. The histopathological hallmark of PK is the cornoid lamella. While many topical, systemic, and surgical treatment modalities for PK have been described, no randomized controlled trials have been performed yet. Because of a lack of treatment standards for PK, European and international guidelines cannot be created.
Objective
The aim of this systematic review is to outline options for treating PK.
Methods
We performed a systematic literature search in an electronic database for published literature. A total of 88 articles fulfilling our inclusion criteria were found.
Results
There were no randomized controlled trials on the treatment of PK, but mainly case reports and case series. Porokeratosis of Mibelli showed the best outcomes after treatment with imiquimod cream and linear PK responded well to topical or systemic retinoids. Topical vitamin D acid derivatives may be the best therapeutic option for disseminated PK. Surgical interventions and cryotherapy may be preferred in areas where the use of topical agents is difficult or contraindicated.
Conclusion
To offer patients with PK an evidence-based high-quality standardized therapy, randomized controlled trials are needed.
Similar content being viewed by others
References
Allegra F. The man behind the eponym. Vittorio Mibelli and the tale of “porokeratosis”. Am J Dermatopathol. 1986;8(2):169–72.
Levitt JO, Keeley BR, Phelps RG. Treatment of porokeratosis of Mibelli with cantharidin. J Am Acad Dermatol. 2013;69(5):e254–5. doi:10.1016/j.jaad.2013.06.021.
Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol. 2014;24(5):533–44. doi:10.1684/ejd.2014.2402.
Sertznig P, von Felbert V, Megahed M. Porokeratosis: present concepts. J Eur Acad Dermatol Venereol. 2012;26(4):404–12. doi:10.1111/j.1468-3083.2011.04275.x.
Wade TR, Ackerman AB. Cornoid lamellation: a histologic reaction pattern. Am J Dermatopathol. 1980;2(1):5–15.
Sasson M, Krain AD. Porokeratosis and cutaneous malignancy: a review. Dermatol Surg. 1996;22(4):339–42.
Lederman JS, Sober AJ, Lederman GS. Immunosuppression: a cause of porokeratosis? J Am Acad Dermatol. 1985;13(1):75–9.
Vire G, Latour D, King LE Jr. Porokeratosis and immunosuppression. J Am Acad Dermatol. 1986;14(4):683–4.
Kanitakis J, Euvrard S, Faure M, Claudy A. Porokeratosis and immunosuppression. Eur J Dermatol. 1998;8(7):459–65.
Zhang SQ, Jiang T, Li M, et al. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis. Nat Genet. 2012;44(10):1156–60. doi:10.1038/ng.2409.
Zhou Y, Liu J, Fu X, et al. Identification of three novel frameshift mutations of the MVK gene in four Chinese families with disseminated superficial actinic porokeratosis. Br J Dermatol. 2013;169(1):193–5. doi:10.1111/bjd.12224.
Neumann RA, Knobler RM, Jurecka W, Gebhart W. Disseminated superficial actinic porokeratosis: experimental induction and exacerbation of skin lesions. J Am Acad Dermatol. 1989;21(6):1182–8.
Kawara S, Oiso N, Kawada A. Disseminated superficial actinic porokeratosis in a patient undergoing treatment with long-term narrowband ultraviolet B for psoriasis. J Dermatol. 2011;38(6):585–7. doi:10.1111/j.1346-8138.2010.01099.x.
Parish JL. Topical vitamin D3 analogues: unapproved uses, dosages, or indications. Clin Dermatol. 2002;20(5):558–62.
Nakamura Y, Yamaguchi M, Nakamura A, Muto M. Calcipotriol and adapalene therapy for disseminated superficial actinic porokeratosis. Indian J Dermatol Venereol Leprol. 2014;80(4):373–4. doi:10.4103/0378-6323.136981.
Noborio R, Morita A. Split-face trial of CO(2) laser-induced ring abrasion and high-dose tacalcitol in the treatment of disseminated superficial actinic porokeratosis. J Dermatol. 2012;39(10):879–80. doi:10.1111/j.1346-8138.2011.01461.x.
Abe M, Yokoyama Y, Ishikawa O. Successful treatment of disseminated superficial actinic porokeratosis with tacalcitol lotion. J Dermatol. 2010;37(10):913–5. doi:10.1111/j.1346-8138.2010.00902.x.
Asawanonda P, Noppakun N, Huiprasert P. Seborrheic keratosis-like porokeratosis: a case report. Dermatol Online J. 2005;11(1):18.
Bohm M, Luger TA, Bonsmann G. Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol. 1999;40(3):479–80.
Harrison PV, Stollery N. Disseminated superficial actinic porokeratosis responding to calcipotriol. Clin Exp Dermatol. 1994;19(1):95.
Tchernev G, Chokoeva AA, Ivanova B, et al. Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel? Wien Med Wochenschr. 2016;. doi:10.1007/s10354-016-0484-8 (Epub ahead of print).
Bakardzhiev I, Kavaklieva S, Pehlivanov G. Successful treatment of disseminated superficial actinic porokeratosis with calcipotriol. Int J Dermatol. 2012;51(9):1139–42. doi:10.1111/j.1365-4632.2010.04704.x.
Kohara Y, Takeo T, Oshima Y, et al. Linear porokeratosis with nail dystrophy. Eur J Dermatol. 2011;21(4):625–6. doi:10.1684/ejd.2011.1393.
Fritsch PO. Retinoids in psoriasis and disorders of keratinization. J Am Acad Dermatol. 1992;27(6 Pt 2):S8–14.
Garg T, Ramchander Varghese B, et al. Generalized linear porokeratosis: a rare entity with excellent response to acitretin. Dermatol Online J. 2011;17(5):3.
Hong JB, Hsiao CH, Chu CY. Systematized linear porokeratosis: a rare variant of diffuse porokeratosis with good response to systemic acitretin. J Am Acad Dermatol. 2009;60(4):713–5. doi:10.1016/j.jaad.2008.10.011.
Dervis E, Demirkesen C. Generalized linear porokeratosis. Int J Dermatol. 2006;45(9):1077–9. doi:10.1111/j.1365-4632.2004.02490.x.
Grover C, Goel A, Nanda S, et al. A case of extensive linear porokeratosis with evaluation of topical tretinoin versus 5-flourouracil as treatment modalities. J Dermatol. 2005;32(12):1000–4.
Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol. 1995;131(4):496–7.
Borroni RG, Poddighe D, Zecca M, Brazzelli V. Efficacy of acitretin for porokeratosis in a child with chronic cutaneous graft versus host disease. Pediatr Dermatol. 2013;30(1):148–50. doi:10.1111/j.1525-1470.2011.01610.x.
Uuskula A, Erm T. Disseminated giant hyperkeratotic porokeratosis and treatment with acitretin: a case report. Acta Derm Venereol. 2015;95(2):241–2. doi:10.2340/00015555-1908.
Hartman R, Mandal R, Sanchez M, Stein JA. Porokeratosis plantaris, palmaris, et disseminata. Dermatol Online J. 2010;16(11):22.
Skroza N, Proietti I, Bernardini N, et al. Acitretin for treatment of familial porokeratosis palmaris et plantaris disseminate. Eur J Dermatol. 2012;22(5):699–700. doi:10.1684/ejd.2012.1826.
Kumar SS, Lee S. Genitogluteal porokeratosis: an unusual clinical presentation. Aust J Dermatol. 2012;53(2):e36–9. doi:10.1111/j.1440-0960.2011.00784.x.
Tallon B, Blumental G, Bhawan J. Porokeratosis ptychotropica: a lesser-known variant. Clin Exp Dermatol. 2009;34(8):e895–7. doi:10.1111/j.1365-2230.2009.03664.x.
Uenishi T, Teramura K, Kitamura M, et al. Hyperkeratotic variant of porokeratosis Mibelli with dermal amyloid deposits. J Dermatol. 2010;37(5):475–9. doi:10.1111/j.1346-8138.2010.00803.x.
Gotz A, Kopera D, Wach F, et al. Porokeratosis Mibelli gigantea: case report and literature review]. [Article in German. Hautarzt. 1999;50(6):435–8.
Agrawal SK, Gandhi V, Madan V, Bhattacharya SN. Topical tretinoin in Indian male with zosteriform porokeratosis. Int J Dermatol. 2003;42(11):919–20.
Gutierrez EL, Galarza C, Ramos W, et al. Facial porokeratosis: a series of six patients. Aust J Dermatol. 2010;51(3):191–4. doi:10.1111/j.1440-0960.2009.00616.x.
Suarez-Amor O, Pereiro-Ferreiros M, Ginarte M, et al. Coexistence of linear porokeratosis and disseminated superficial actinic porokeratosis: a type 2 segmental manifestation. Acta Derm Venereol. 2007;87(4):363–4. doi:10.2340/00015555-0215.
Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 Pt 2):S6–11.
Gajic B, Tang K, Whitfeld M. Porokeratosis of Mibelli: involution and resolution with 5% imiquimod cream. Aust J Dermatol. 2011;52(4):301–3. doi:10.1111/j.1440-0960.2010.00712.x.
Esser AC, Pittelkow MR, Randle HW. Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream. Dermatol Surg. 2006;32(6):858–61. doi:10.1111/j.1524-4725.2006.32176.x.
Jain S. Successful treatment of porokeratosis of Mibelli with imiquimod 5% cream. Clin Exp Dermatol. 2006;31(2):302–3. doi:10.1111/j.1365-2230.2005.02044.x.
Agarwal S, Berth-Jones J. Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream. Br J Dermatol. 2002;146(2):338–9.
Montes-De-Oca-Sanchez G, Tirado-Sanchez A, Garcia-Ramirez V. Porokeratosis of Mibelli of the axillae: treatment with topical imiquimod. J Dermatol Treat. 2006;17(5):319–20. doi:10.1080/09546630600944116.
Gracia-Cazana T, Vera-Alvarez J, Garcia-Patos V, Gilaberte Y. Imiquimod and photodynamic therapy are useful in the treatment of porokeratosis in children with bone marrow transplantation. Pediatr Dermatol. 2015;32(6):e291–3. doi:10.1111/pde.12654.
Erbagci Z, Tuncel AA, Erbagci I. Successful treatment of porokeratosis with topical imiquimod in 2 immunosuppressed cases. J Drugs Dermatol. 2006;5(7):668–71.
Arun B, Pearson J, Chalmers R. Disseminated superficial actinic porokeratosis treated effectively with topical imiquimod 5% cream. Clin Exp Dermatol. 2011;36(5):509–11. doi:10.1111/j.1365-2230.2011.04064.x.
Ahn SJ, Lee HJ, Chang SE, et al. Case of linear porokeratosis: successful treatment with topical 5% imiquimod cream. J Dermatol. 2007;34(2):146–7. doi:10.1111/j.1346-8138.2006.00236.x.
Kindem S, Serra-Guillen C, Sorni G, et al. Treatment of porokeratosis of Mibelli with ingenol mebutate: a possible new therapeutic option. JAMA Dermatol. 2015;151(1):85–6. doi:10.1001/jamadermatol.2014.2697.
Moore AY. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders. J Dermatol Treat. 2009;20(6):328–35. doi:10.3109/09546630902789326.
Harrison S, Sinclair R. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream. Aust J Dermatol. 2003;44(4):281–3.
Chowdhury MM, Inaloz HS, Holt PJ. A scaly macule on the bridge of the nose of a 15-year-old boy. Pediatr Dermatol. 2000;17(2):149–50.
Danby W. Treatment of porokeratosis with fluorouracil and salicylic acid under occlusion. Dermatol Online J. 2003;9(5):33.
Venkatarajan S, LeLeux TM, Yang D, et al. Porokeratosis of Mibelli: successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatol Online J. 2010;16(12):10.
Teixeira SP, de Nascimento MM, Bagatin E, et al. The use of fluor-hydroxy pulse peel in actinic porokeratosis. Dermatol Surg. 2005;31(9 Pt 1):1145–8.
Zhan H, Zheng H. The role of topical cyclo-oxygenase-2 inhibitors in skin cancer: treatment and prevention. Am J Clin Derm. 2007;8(4):195–200.
Marks S, Varma R, Cantrell W, et al. Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23(1):42–5. doi:10.1111/j.1468-3083.2008.02943.x.
Kluger N, Dereure O, Guilhou JJ, Guillot B. Genital porokeratosis: treatment with diclofenac topical gel. J Dermatol Treat. 2007;18(3):188–90. doi:10.1080/09546630701258101.
Vlachou C, Kanelleas AI, Martin-Clavijo A, Berth-Jones J. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series. J Eur Acad Dermatol Venereol. 2008;22(11):1343–5. doi:10.1111/j.1468-3083.2008.02842.x.
Tee SI, Chong WS. Eruptive pruritic papular porokeratosis. Indian J Dermatol Venereol Leprol. 2012;78(6):758–60. doi:10.4103/0378-6323.102384.
Verma KK, Singh OP. Dexamethasone pulse treatment in disseminated porokeratosis of Mibelli. J Dermatol Sci. 1994;7(1):71–2.
Klein N, Enk A, Hartschuh W. Inflammatory stage of disseminated superficial porokeratosis in a 71-year old patient]. [Article in German. Hautarzt. 2009;60(5):420–3. doi:10.1007/s00105-008-1639-3.
Chen TJ, Chou YC, Chen CH, et al. Genital porokeratosis: a series of 10 patients and review of the literature. Br J Dermatol. 2006;155(2):325–9. doi:10.1111/j.1365-2133.2006.07295.x.
Kim DS, Roh MR, Lee JH, Lee KH. Pterygium unguis formation in porokeratosis of Mibelli. Br J Dermatol. 2007;156(6):1384–5. doi:10.1111/j.1365-2133.2007.07887.x.
Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs. 2005;65(6):827–58.
Parks AC, Conner KJ, Armstrong CA. Long-term clearance of linear porokeratosis with tacrolimus, 01%, ointment. JAMA Dermatol. 2014;150(2):194–6. doi:10.1001/jamadermatol.2013.8526.
Rabbin PE, Baldwin HE. Treatment of porokeratosis of Mibelli with CO2 laser vaporization versus surgical excision with split-thickness skin graft: a comparison. J Dermatol Surg Oncol. 1993;19(3):199–202.
Merkle T, Hohenleutner U, Braun-Falco O, Landthaler M. Reticulate porokeratosis: successful treatment with CO2-laser vaporization. Clin Exp Dermatol. 1992;17(3):178–81.
Hernandez-Bel P, Sanmartin-Jimenez O, Sorni-Broker G, Guillen-Barona C. Labial porokeratosis. Am J Dermatopathol. 2010;32(6):638. doi:10.1097/DAD.0b013e3181caac93.
Kim HS, Baek JH, Park YM, et al. Photodynamic therapy combined with CO(2) laser vaporization on disseminated superficial actinic porokeratosis: a report of 2 cases on the face. Ann Dermatol. 2011;23(Suppl. 2):S211–3. doi:10.5021/ad.2011.23.S2.S211.
McCullough TL, Lesher JL Jr. Porokeratosis of Mibelli: rapid recurrence of a large lesion after carbon dioxide laser treatment. Pediatr Dermatol. 1994;11(3):267–70.
Itoh M, Nakagawa H. Successful treatment of disseminated superficial actinic porokeratosis with Q-switched ruby laser. J Dermatol. 2007;34(12):816–20. doi:10.1111/j.1346-8138.2007.00392.x.
Lee DK, Oh SH, Chang SE, et al. A rare variant of porokeratosis: porokeratosis ptychotropica. J Am Acad Dermatol. 2006;55(5 Suppl.):S120–2. doi:10.1016/j.jaad.2005.12.009.
Liu Y, Wang Y, Nie X, et al. Treatment of classic porokeratosis of Mibelli with Q-switched ruby laser. Eur J Dermatol. 2012;22(1):125–6. doi:10.1684/ejd.2011.1552.
Lolis MS, Marmur ES. Treatment of disseminated superficial actinic porokeratosis (DSAP) with the Q-switched ruby laser. J Cosmet Laser Ther. 2008;10(2):124–7. doi:10.1080/14764170802068971.
Rosenblum J, Roenigk HH Jr. Erbium laser for the treatment of disseminated superficial actinic porokeratosis: a case report. Dermatol Surg. 2013;39(10):1543–5. doi:10.1111/dsu.12261.
Liu HT. Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg. 2000;26(10):958–62.
Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Fractional photothermolysis: a novel treatment for disseminated superficial actinic porokeratosis. Arch Dermatol. 2007;143(11):1450–2. doi:10.1001/archderm.143.11.1450.
Alster TS, Nanni CA. Successful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis. 1999;63(5):265–6.
Ricci C, Rosset A, Panizzon RG. Bullous and pruritic variant of disseminated superficial actinic porokeratosis: successful treatment with grenz rays. Dermatology. 1999;199(4):328–31. doi:10.1159/000018284.
Wolf P. Photodynamic therapy in dermatology: state of the art. J Eur Acad Dermatol Venereol. 2001;15(6):508–9.
Fernandez-Guarino M, Harto A, Perez-Garcia B, et al. Photodynamic therapy in disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol. 2009;23(2):176–7. doi:10.1111/j.1468-3083.2008.02753.x.
Cavicchini S, Tourlaki A. Successful treatment of disseminated superficial actinic porokeratosis with methyl aminolevulinate-photodynamic therapy. J Dermatol Treat. 2006;17(3):190–1. doi:10.1080/09546630600788869.
Calzavara-Pinton PG, Rossi MT, Italian Group For Photodynamic T, et al. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1: inflammatory and aesthetic indications. Photochem Photobiol Sci. 2013;12(1):148–57. doi:10.1039/c2pp25124h.
Gutierrez Paredes E, Bella Navarro R, Montesinos Villaescusa E, Jorda Cuevas E. Porokeratosis of Mibelli: a new indication for photodynamic therapy? Actas Dermosifiliogr. 2013;104(3):259–61. doi:10.1016/j.ad.2012.04.016.
Giuliodori K, Campanati A, Ganzetti G, et al. The successful off-label use of photodynamic therapy for classic porokeratosis of Mibelli: case report. Dermatol Ther. 2011;24(5):501–4. doi:10.1111/j.1529-8019.2012.01473.x.
Curkova AK, Hegyi J, Kozub P, et al. A case of linear porokeratosis treated with photodynamic therapy with confocal microscopy surveillance. Dermatol Ther. 2014;27(3):144–7. doi:10.1111/dth.12097.
Garcia-Navarro X, Garces JR, Baselga E, Alomar A. Linear porokeratosis: excellent response to photodynamic therapy. Arch Dermatol. 2009;145(5):526–7. doi:10.1001/archdermatol.2009.45.
Boiy A, de Witte PA, Roelandts R. Topical treatment of disseminated superficial actinic porokeratosis with hypericin-photodynamic therapy: a case report. Photodiagnosis Photodyn Ther. 2010;7(2):123–5. doi:10.1016/j.pdpdt.2010.02.003.
Garrido-Colmenero C, Ruiz-Villaverde R, Martinez-Garcia E, et al. Photoletter to the editor: response of linear porokeratosis to photodynamic therapy in an 11-year-old girl. J Dermatol Case Rep. 2015;9(4):118–9. doi:10.3315/jdcr.2015.1220.
Nayeemuddin FA, Wong M, Yell J, Rhodes LE. Topical photodynamic therapy in disseminated superficial actinic porokeratosis. Clin Exp Dermatol. 2002;27(8):703–6.
Levitt J, Emer JJ, Emanuel PO. Treatment of porokeratosis of mibelli with combined use of photodynamic therapy and fluorouracil cream. Arch Dermatol. 2010;146(4):371–3. doi:10.1001/archdermatol.2010.28.
Salas T, Hernandez-Gil J, Lopez A, et al. Two cases of disseminated superficial actinic porokeratosis treated with daylight-mediated photodynamic therapy. Dermatol Ther. 2016;29(6):484–5. doi:10.1111/dth.12389.
Piccolo D, Di Marcantonio D, Crisman G, et al. Unconventional use of intense pulsed light. BioMed Res Int. 2014;2014:618206. doi:10.1155/2014/618206.
Spencer JM, Katz BE. Successful treatment of porokeratosis of Mibelli with diamond fraise dermabrasion. Arch Dermatol. 1992;128(9):1187–8.
Cohen PR, Held JL, Katz BE. Linear porokeratosis: successful treatment with diamond fraise dermabrasion. J Am Acad Dermatol. 1990;23(5 Pt 2):975–7.
Alexis AF, Busam K, Myskowski PL. Porokeratosis of Mibelli following bone marrow transplantation. Int J Dermatol. 2006;45(4):361–5. doi:10.1111/j.1365-4632.2006.02509.x.
Otani Y, Katagiri K, Takeuchi Y, et al. A case of giant porokeratosis with vestiges of a cornoid lamella. J Dermatol. 2005;32(11):894–8.
Scheiba N, Enk A, Proske S, Hartschuh W. Porokeratosis ptychotropica: successful treatment with the dermatome. Dermatol Surg. 2010;36(2):257–60. doi:10.1111/j.1524-4725.2009.01402.x.
Robinson JB, Im DD, Jockle G, Rosenshein NB. Vulvar porokeratosis: case report and review of the literature. Int J Gynecol Pathol. 1999;18(2):169–73.
Yazkan F, Turk BG, Dereli T, Kazandi AC. Porokeratosis of Mibelli induced by topical corticosteroid. J Cutan Pathol. 2006;33(7):516–8. doi:10.1111/j.1600-0560.2006.00464.x.
Levell NJ, Bewley AP, Levene GM. Porokeratosis of Mibelli on the penis, scrotum and natal cleft. Clin Exp Dermatol. 1994;19(1):77–8.
Bhushan M, Craven NM, Beck MH, Chalmers RJ. Linear porokeratosis of Mibelli: successful treatment with cryotherapy. Br J Dermatol. 1999;141(2):389.
Vergara G, Banuls J, Botella R, et al. Porokeratosis of the lower lip. Eur J Dermatol. 2002;12(5):500–2.
Goncalves SV, Valente NY, Oliveira Jrunior JV, Paiva DL. Case for diagnosis. An Braz Dermatol. 2012;87(3):489–90.
Dereli T, Ozyurt S, Ozturk G. Porokeratosis of Mibelli: successful treatment with cryosurgery. J Dermatol. 2004;31(3):223–7.
Acknowledgements
The authors are indebted to Melanie Peckruhn for providing the dermatopathological photograph.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No sources of funding were received for the preparation of this article.
Conflict of interest
T Weidner, T. Illing, D. Miguel, and P. Elsner have no conflicts of interest directly relevant to the content of this article.
Rights and permissions
About this article
Cite this article
Weidner, T., Illing, T., Miguel, D. et al. Treatment of Porokeratosis: A Systematic Review. Am J Clin Dermatol 18, 435–449 (2017). https://doi.org/10.1007/s40257-017-0271-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-017-0271-3